瘤学的多维策略:从宏循环激酶抑制剂到物理化学和转录基因诊断
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ACS medicinal chemistry letters
|January 14, 2026
概括
精确瘤学的进展包括针对非小细胞肺癌 (NSCLC) 的新型ALK抑制剂,无标签cfDNA分期,以及基于转录基因的KRAS抑制剂反应预测. 这些创新改进了癌症治疗选择,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 精准瘤学旨在为个别患者量身定制癌症治疗方法.
- 分子诊断和向治疗的进步对于改善患者的治疗结果至关重要.
- 当前的挑战包括耐药性和准确的患者分层.
研究的目的:
- 突出精确瘤学的最近的互补进展.
- 展示针对性治疗,诊断和预测生物标志物的创新.
- 为了说明一个集成分子,生物物理和计算方法的新范式.
主要方法:
- 开发用于耐性非小细胞肺癌 (NSCLC) 的宏循环多向性形淋巴瘤激酶 (ALK) 抑制剂.
- 基于阻抗的无细胞DNA (cfDNA) 阶段测定用于无标签的癌症诊断.
- 使用转录组驱动分析来预测对KRAS抑制剂的反应.
主要成果:
- 宏循环多标ALK抑制剂显示出克服NSCLC抵抗的希望.
- 基于阻抗的cfDNA分期提供了一种新的无标签诊断方法.
- 转录组分析能够预测患者对KRAS抑制剂的反应.
结论:
- 这些发明代表了瘤学的重大补充进步.
- 精密瘤学的新兴范式整合了分子设计,生物物理分类和计算表型.
- 这种综合性方法完善了治疗选择,并有可能改善癌症患者的临床结果.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


